1. INTRODUCTION
===============

Antimicrobial agents also called antibiotics are the crucial drugs obtained from microorganisms to prevent and treat bacterial infections. The role of antibiotics came into action when Alexander Fleming discovered the penicillin in 1928 \[[@r1]\]. Most of the (about 75%) antibiotics that are currently in clinical use are obtained from actinobacteria isolated either from soil or water \[[@r2]-[@r4]\]. To date, continuous uses of antibiotics have created ineffectiveness to antibiotics, leading global rise in drug-resistant bacteria \[[@r5]\]. In recent years, several microbial infectious diseases are no longer responding to commonly used antimicrobial drugs which have elevated multi-drug resistance. The rise and spread of resistant bacteria is a major threat to public health and a unique challenge to both science and medicine \[[@r6]\]. Multi-drug Resistant (MDR) organisms (*Enterococcus* spp., *Klebsiella* spp., *Enterobacter* spp., *Staphylococcus aureus*, *Pseudomonas aeruginosa*, *Acinetobacter baumannii*, *Propionibacterium acnes*, *Staphylococcus epidermidis*, *Escherichia coli*, and *Mycobacterium tuberculosis*) are considered as clinical threat to human and animals \[[@r7]-[@r12]\]. The Center for Disease Control and Prevention (CDC) assessed antimicrobial-resistant microbial infections according to various aspects: clinical impact, economic impact, incidence, 10-year projection of incidence, transmissibility, availability of effective antibiotics, and barriers to prevention \[[@r13], [@r14]\].

Antimicrobial resistance occurs when pathogenic bacteria degrade antibacterial drugs, alter bacterial proteins, and modify membrane permeability to antibiotics \[[@r15]\]. Taking antibiotics without doctor's prescription as well as medicating antibiotics unnecessarily for treatment of normal viral illness such as common cold, is a good example for increment of antimicrobial resistance \[[@r16], [@r17]\]. The CDC estimates that antibiotic resistance is responsible for more than two million infections and 23,000 deaths each year in the United States \[[@r18]\]. The therapeutic consumption of antibiotics is increasing continuously and the demands of antibiotics continue to rise exponentially. In a decade of 2000-2010, the total global antibiotic consumption was raised by 30% \[[@r19]\].

Similar as global issue, the antimicrobial-resistance is also a serious complication in Nepal. However, there are no sufficient surveillance system for tracking current antibiotic use and its resistant pattern in Nepal. In addition, few research and published literatures are not abundant to elucidate current scenario. It is truly difficult to report exact trends of antibiotic use and its resistance in Nepal. Therefore, this review accentuates the antibiotic discovery and resistance, the current trends of antibiotic use, its resistance, and extending antibiotic effectiveness in the context of Nepal.

2. ANTIMICROBIAL RESISTANCE OF VARIOUS MICROBIAL PATHOGENS
==========================================================

Various antimicrobial agents, effective previously, are no longer useful today because of rise of resistance genes in the microbial genome \[[@r20]\]. Resistance genes emerge through natural selection in the environment over long period of time or by spontaneous mutation in the microbial DNA \[[@r21]\]. Resistant pattern has been reported by almost all antibiotics that have been developed so far (Fig. **[1](#F1){ref-type="fig"}**). The infections caused by antimicrobial-resistant microorganisms often fail to respond to the standard treatment or drug therapy, which result prolonged illness and fatal risk \[[@r22]\].

The main cause of premature mortality and morbidity in Nepal are from bacterial origin. Major infections include acute respiratory infections, diarrheal disease, tuberculosis, and bloodstream infections. For inpatient morbidity, out of 287,616 hospitalized patients in 2014-2015, 11,529 patients were hospitalized due to diarrhea and gastroenteritis followed by other chronic obstructive pulmonary disease (8,053) and unspecified acute lower respiratory infections (7,881), which were the leading cause for hospitalization \[[@r23]\]. Pneumonia, diarrhea, and sepsis are the major health risk for neonates and infants. However, under-five, the infant and neonatal mortality in Nepal have been decreased by 79.59% in the year 1990-2015 \[[@r24]\]. There were 502 new diarrheal cases per 1,000 children under five years in 2014-2015 and number of diarrheal death were 80 \[[@r24]\].

2.1. Enteric Pathogens
----------------------

Enteric microbial pathogens are those that cause severe diarrhea and dysentery which include rotavirus, *Shigella* spp., *Vibrio cholerae*, *Salmonella* spp., enterotoxigenic *Escherichia coli* (ETEC), enteroaggregative *Escherichia coli* (EAEC) and *Campylobacter* spp \[[@r25]\]. In most of the diarrheal cases, antibiotics are not required for complete recovery except some complications like bloody diarrhea. However, antibiotics are often used to treat in most diarrheal cases inappropriately \[[@r26]\].

*Vibrio cholerae* is a causative agent for severe watery diarrhea, which can lead to dehydration and even death. It is usually caused due to contaminated water or food. In Nepal, cholera outbreak is still a serious issue. Nearly, all *Vibrio cholerae* isolates (clinical and environmental) were resistant to cotrimoxazole, nalidixic acid, furazolidone, erythromycin, and ampicillin \[[@r27]-[@r30]\]. In addition, resistant strains of *Vibrio cholerae* were also reported for antibiotics chloramphenicol and ciprofloxacin (Table **[1](#T1){ref-type="table"}**).

In the study of *Salmonella* and *Shigella* spp., most of the species were reported to have multi-drug resistance \[[@r31]-[@r35]\]. Cotrimoxazole and nalidixic acid were found to be 100% resistant towards 15 isolates of *Shigella boydii* and ampicillin was unable to inhibit 6 isolates of *Shigella sonnei* \[[@r31]\]. Multi-drug resistant species of *Salmonella* and *Shigella* were well distributed, which have attributed Shigellosis and Salmonellosis to the public health. A systematic meta-analysis of antibiotic resistance conduced for 2 decades (1993-2011) showed that two species of *Salmonella* (*Salmonella* Typhi and *Salmonella* Paratyphi A) were responsible for typhoid and paratyhoid enteric fever \[[@r36]\]. For both strains, *Salmonella* Typhi and *Salmonella* Paratyphi A, resistance to nalidixic acid and ciprofloxacine were sharply increased. However, for both strains, resistance to first-line antibiotics chloramphenicol and cotrimoxazole were in decreasing trends \[[@r36]\]. In contrast, nalidixic acid was more resistant compared to chloramphenicol and cotrimoxazole. These results suggest that the chloramphenicol and cotrimoxazole are still useful for typhoid and paratyhoid enteric fever treatment (Table **[2](#T2){ref-type="table"}**).

2.2. Uropathogens
-----------------

Urinary Tract Infection (UTI) is one of the most common infectious diseases caused by *E. coli*. In addition, *Klebsiella* spp., *Enterococcus* spp., *Enterobacter* spp., *Citrobacter* spp., and *Proteus* spp. are also associated with UTI. A report by Nepal's National Public Health Laboratory demonstrated that the resistance rates of *E. coli* for various antibiotics amoxyicillin, cefixime, nalidixic acid, ceftazidime, ciprofloxacin, cotrimoxazole, norfloxacin, ofloxacin, and cefotaxime were above 50% and showed increased trend of antibiotic resistance in the year 2006 to 2010 \[[@r37]\]. Extended Spectrum Beta Lactamase (ESBL) producing *E. coli* exhibited 100% resistance to cephalosporins which revealed ineffectiveness in the treatment of UTI (Table **[3](#T3){ref-type="table"}**). However, MDR *E. coli* and ESBL *E. coli* were susceptible (100%) to tigecycline, colistin, and amikacin reserving antimicrobial treatment \[[@r38], [@r39]\].

2.3. Pneumococcal Pathogens
---------------------------

Pneumococcal disease is an inflammatory condition of the lung. *Streptococcus pneumoniae*, *Klebsiella pneumoniae*, *Staphylococus aureus*, *Haemophilus influenza* type b (Hib), and *Pseudomonas aeruginosa* are common bacteria that are responsible for pneumonia in Nepal \[[@r26]\]. Common antibiotics used for pneumonia treatment in Nepal were cotrimoxazole, amoxicillin, and chloramphenicol \[[@r40]\]. In contrast, antimicrobial resistance to commonly used antibiotics ciprofloxacin and cotrimoxazole were highly increased from 2000 to 2008 \[[@r41]\]. Various studies reported that most of the antibiotics resistant strains of *Streptococcus pneumoniae* and *Klebsiella pneumoniae* were from clinical isolates of respiratory infections \[[@r42]-[@r46]\]. The antibiotics resistant for *Klebsiella* spp., *Streptococcus pneumoniae*, *Haemophilus influenzae*, and *Pseudomonas aeruginosa* are constantly increasing in recent years (Table **[4](#T4){ref-type="table"}**) \[[@r47]-[@r49]\].

2.4. Bacteremic Pathogens
-------------------------

Bacteremia is well known as bacterial bloodstream infections. Serious bacterial infections include neonatal sepsis, meningitis, cellulitis, osteomyelitis, brain abscesses, pneumonia, and typhoid \[[@r50]\]. These infections are often serious and possibly resulting in death which requires prompt antibiotic treatment. Out of 120 isolates, 30.8% neonatal sepsis positive cases were observed in neonatal intensive care unit of Nepal Medical College Teaching Hospital (NMCTH), Kathmandu, Nepal. Among them, 56.8% were resulted from *Staphylococcus aureus* infection followed by *Klebsiella pneumoniae* (21.7%), *Pseudomonas aeruginosa* (13.4%) and others \[[@r51]\]. However, the resistance over different antibiotics was also frequent. Studies of sepsis infections in different hospitals reported the resistance of *Staphylococcus aureus*, *Klebsiella pneumoniae*, *Pseudomonas* spp., *Acinetobacter* spp., *Enterobacter* spp., *Citrobacter* spp., *E. coli*, and *Proteus mirabilis* ranged from 25 to 100% against commonly used antibiotics oxacillin, erythromycin, clindamycin, penicillin, cephalexin, cotrimoxazole, gentamicin, amikacin, ofloxacin, cefixime, cefotaxime, ceftazidime, piperacillin, imipenem, piperacillin-tazobactam, and ampicillin \[[@r51]-[@r57]\].

2.5. Tuberculosis Pathogens
---------------------------

Tuberculosis (TB) is an infectious disease caused by *Mycobacterium tuberculosis*. Resistance of *M. tuberculosis* to first line drugs isoniazid and rifampicin were extensively being increased \[[@r58]\]. The results of drug resistance survey (2011-2012) showed that the levels of drug resistance were high in Nepal, with nearly 9.3% of new patients and resistance among treatment cases were 15.4% \[[@r59]\]. In addition, the trends of Multi-Drug Resistant Tuberculosis (MDR-TB) were increased from 18.6% to 22.3% in the years 2010--2014 \[[@r59]\]. Furthermore, 61 new MDR-TB cases were registered in 2014 to 2015 \[[@r60]\]. These studies showed that the prevalence of resistance to the first-line tuberculosis drugs rifampicin and isoniazid against MDR-TB has been increased in Nepal.

2.6. Nosocomial Pathogens
-------------------------

Nosocomial infection is a major Healthcare Associated Infection (HCAI) in Nepal. HCAI and antimicrobial resistance were the principal threats to the patients of intensive care unit \[[@r61]\]. High prevalence of Methicillin-resistance *Staphylococcus aureus* (MRSA) and other bacteria were reported in most of the HCAI studies \[[@r62]-[@r69]\]. Currently, in Nepal, MDR *S. aureus* and MRSA is a major clinical threat to public health. One of the major consequences of reporting high rates of multi-drug resistant MRSA is exploitation of vancomycin (Table **[5](#T5){ref-type="table"}**).

2.7. Sexually Transmitted Pathogens
-----------------------------------

Syphilis and gonorrhea are sexually transmitted infections of mucous membrane surfaces caused by *Treponema pallidum* and *Neisseria gonorrhoeae*, respectively. Studies on antibiotic resistance against sexually transmitted infections remain limited in Nepal. However, few identified studies reported high rate of resistance of *Neisseria gonorrhoeae* to antibiotics penicillin, tetracycline, and ciprofloxacin \[[@r70]-[@r72]\].

2.8. Wound-Infection Pathogens
------------------------------

Wound-infection is one of the crucial health problem caused by the invasion of pathogenic microbes. Wound is an injury to the body by laceration or breaking of skin either from surgery, accident, war, animal bites or violence \[[@r73]\]. Post-operative wound-infections and injuries among children are the major health risks in Nepal \[[@r74]-[@r77]\]. Both gram positive and gram negative bacteria are associated with wound-infection. Most of the identified studies have reported *S. aureus*, *S. epidermidis*, MRSA, *E. coli*, *K. pneumoniae*, *P. aeruginosa*, *Proteus vulgaris*, *Proteus mirabilis*, *Enterococcus* spp., *Enterobacter* spp., and *Acinetobacter* spp. were associated with wound-infections \[[@r74]-[@r79]\]. Common antibiotics used for wound infections were amoxicillin (41-70% resistant), amikacin (16-80% resistant), gentamicin (19-75% resistant), cotrimoxazole (37-100% resistant), ofloxacin (23-100% resistant), ciprofloxacin (20-100% resistant), and cephalexin (40-100% resistant) \[[@r76]-[@r79]\]. The increasing multi-drug resistant wound infections are the serious issue. *S. aureus* and *E. coli* remained the most frequently isolated etiological agent for wound infection \[[@r74], [@r75], [@r78], [@r79]\]. In addition, hospital acquired wound infection; especially post operational infection has severe consequences on health and wealth burden for In-patients.

3. PREVENTIVE MEASURES
======================

The antimicrobial resistance is a huge prime global hurdle and exponentially increasing in Nepal as well and must be addressed promptly and appropriately. Prescribing antimicrobial drugs unnecessarily, over and under dose medication of antibiotics, and unauthorized antibiotic dispensing by drug retailers are principal issues for rapid growth of antimicrobial resistance \[[@r13], [@r14], [@r16], [@r17]\]. Increasing antimicrobial resistance prolongs the illness and results failure with first-line antimicrobial drug treatment which may urge to treat with second-line or third-line drugs \[[@r14]\]. This is usually more expensive than first-line drugs and leads financial burden to the healthcare authorities.

Overall, antimicrobial resistance is increasing enormously. To cope with this problem discovery of new antibiotics may be choice of alternatives. But, only few novel antibiotics are being discovered in past several years. This may create a serious threat in upcoming days to the world's public health. Furthermore, medical cost due to antimicrobial resistance is also increasing in similar pattern. Here, we recommend some strategies to reduce antimicrobial resistance and to improve effectiveness of antibiotics in the context of Nepal based on World Health Organization (WHO) policy package to combat the spread of antimicrobial resistance on World Health Day, 2011 \[[@r80]\].

-   Adopt the guidelines of proper antibiotic use in the hospitals and community healthcare centers.

-   Improve the public health issues and find the path to reduce the need for antibiotics (Proper immunization may be a choice to reduce the use of antibiotics).

-   Increase surveillance and antibiotic tracking system.

-   Make strong policy for antibiotic dispensing by drug retailers.

-   Ensure medical personnel to prescribe only essential drugs of assured quality (even medical personnel prescribe more than one antibiotics for a common disease).

-   Regulate and promote rational use of medicines.

-   Reduce the use of antimicrobial agents in agriculture and animals.

-   Raise the awareness programs about antibiotic resistance and public health crisis.

-   Educate the public, policy makers, and health professionals on sustainable use of antibiotics.

-   Nosocomial infection should be controlled to minimize the spread of resistant bacteria.

-   Prevent transmission of bacterial infections.

CONCLUDING REMARKS
==================

Various species of gram positive and gram negative bacteria are responsible for bacterial infections to humans and animals. Majority of the bacterial isolates are resistant to commonly used antibiotics. Antimicrobial resistance is a consequential concern for Nepal as well as for all countries in the world. Over use, under use, and misuse of antibiotic is a leading cause for its resistance. The lack of proper antibiotic tracking system, AMR (antimicrobial resistance) surveillance, and facilitated laboratories are principal difficulties of Nepal. The appropriate use of antimicrobial drugs and control of spreading resistant bacteria help to maintain the effectiveness of antibiotics. A continuous monitoring and studies on the multidrug resistant bacterial isolates are important measures. In addition, national strategic approach to use antibiotics is utmost emergence to preserve effectiveness of antibiotics for future.
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###### 

Antibiotic resistance in *Vibrio cholerae*.

  Microorganism                               Study Area                                     No. of Isolates   Antibiotics      Resistance (%)   Reference
  ------------------------------------------- ---------------------------------------------- ----------------- ---------------- ---------------- ------------
  *Vibrio cholarae* (Clinical isolate)        Kathmandu city                                 22                Ampicillin       100              \[[@r27]\]
  Nalidixic acid                              100                                                                                                
  Cotrimoxazole                               100                                                                                                
  Erythromycin                                90.9                                                                                               
  Cefotaxime                                  18.2                                                                                               
  Chloramphenicol                             9.1                                                                                                
  Ciprofloxacin                               9.1                                                                                                
  *Vibrio cholarae* (Environmental isolate)   Kathmandu city                                 2                 Ampicillin       100              \[[@r27]\]
  Nalidixic acid                              100                                                                                                
  Cotrimoxazole                               100                                                                                                
  Erythromycin                                100                                                                                                
  Chloramphenicol                             50                                                                                                 
  *Vibrio cholarae*                           National Public Health Laboratory, Kathmandu   31                Ampicillin       100              \[[@r28]\]
  Cotrimoxazole                               100                                                                                                
  Ciprofloxacin                               6.45                                                                                               
  Chloramphenicol                             3.23                                                                                               
  *Vibrio cholarae*                           National Public Health Laboratory, Kathmandu   57                Nalidixic acid   100              \[[@r30]\]
  Cotrimoxazole                               100                                                                                                
  Furazolidone                                100                                                                                                
  Erythromycin                                32                                                                                                 
  Ampicillin                                  26                                                                                                 

###### 

Antibiotic resistance in *Salmonella* spp. and *Shigella* spp.

  Microorganism              Study Area                                                 No. of Isolates   Antibiotics      Resistance (%)   Reference
  -------------------------- ---------------------------------------------------------- ----------------- ---------------- ---------------- ------------
  *Shigella flexneri*        Nepalgunj Medical College and Teaching Hospital            29                Ampicillin       96.55            \[[@r31]\]
  Nalidixic acid             96.55                                                                                                          
  Cotrimoxazole              72.41                                                                                                          
  Ciprofloxacin              62.07                                                                                                          
  Ceftazidime                44.83                                                                                                          
  Ofloxacin                  37.93                                                                                                          
  Ceftriaxone                34.48                                                                                                          
  *Shigella dysemteriae*     19                                                         Nalidixic acid    94.74                             
  Cotrimoxazole              84.21                                                                                                          
  Ampicillin                 73.68                                                                                                          
  Ciprofloxacin              68.42                                                                                                          
  Gentamicin                 36.84                                                                                                          
  Ofloxacin                  21.05                                                                                                          
  *Shigella boydii*          15                                                         Cotrimoxazole     100                               
  Nalidixic acid             100                                                                                                            
  Ampicillin                 73.33                                                                                                          
  Gentamicin                 33.33                                                                                                          
  Cefotaxime                 26.67                                                                                                          
  *Shigella sonnei*          6                                                          Ampicillin        100                               
  Nalidixic acid             83.33                                                                                                          
  Cotrimoxazole              83.33                                                                                                          
  Ciprofloxacin              33.33                                                                                                          
  *Shigella* spp.            National Public Health laboratory, Kathmandu               21                Ampicillin       71.42            \[[@r32]\]
  Cotrimoxazole              66.66                                                                                                          
  Mecillinam                 61.9                                                                                                           
  Nalidixic acid             47.62                                                                                                          
  Ciprofloxacin              23.8                                                                                                           
  *Salmonella* spp.          9                                                          Nalidixic acid    44.44                             
  Ampicillin                 33.33                                                                                                          
  Chloramphenicol            33.33                                                                                                          
  Cotrimoxazole              33.33                                                                                                          
  *Shigella flexneri*        Tribhuvan University Teaching Hospital (TUTH), Kathmandu   12                Amoxycillin      83.33            \[[@r33]\]
  Ampicillin                 66.66                                                                                                          
  Tetracycline               66.66                                                                                                          
  Cotrimoxazole              58.33                                                                                                          
  Ciprofloxacin              58.33                                                                                                          
  Azithromycin               33.33                                                                                                          
  Ceftazidime                8.33                                                                                                           
  *Shigella sonnei*          3                                                          Nalidixic acid    100                               
  Cotrimoxazole              100                                                                                                            
  Ciprofloxacin              100                                                                                                            
  Tetracycline               33.33                                                                                                          
  *Salmonella Typhi*         Alka Hospital, Jawalakhel                                  56                Nalidixic acid   91.1             \[[@r34]\]
  Ampicillin                 1.8                                                                                                            
  *Salmonella* Paratyphi A   30                                                         Nalidixic acid    90                                
  Chloramphenicol            3.3                                                                                                            
  Ciprofloxacin              3.3                                                                                                            
  *Salmonella* spp.          Kathmandu Model Hospital, Kathmandu                        83                Nalidixic acid   83.1             \[[@r35]\]
  Ciprofloxacin              3.6                                                                                                            
  Ampicillin                 2.4                                                                                                            
  Cotrimoxazole              1.2                                                                                                            
  Chloramphenicol            1.2                                                                                                            

###### 

Antibiotic resistance in *Escherichia coli*.

  Microorganism        Study Area or Hospital                            No. of Isolates   Antibiotics   Resistance (%)   Reference
  -------------------- ------------------------------------------------- ----------------- ------------- ---------------- ------------
  *E. coli* (ESBL)\*   National Kidney Center, Vanasthali, Kathmandu     18                Cefotaxime    100              \[[@r38]\]
  Ceftazidime          100                                                                                                
  Ceftriaxone          100                                                                                                
  Cefixime             94.44                                                                                              
  Cefalexin            94.44                                                                                              
  Nalidixic acid       94.44                                                                                              
  Norfloxacin          94.44                                                                                              
  Ofloxacin            88.89                                                                                              
  Ciprofloxacin        88.89                                                                                              
  Doxycycline          72.22                                                                                              
  Cotrimoxazole        61.11                                                                                              
  Nitrofurantoin       27.78                                                                                              
  Amikacin             0                                                                                                  
  *E. coli* (ESBL)     Manamohan Medical College and Teaching Hospital   288               Ampicillin    100              \[[@r39]\]
  Amoxicillin          100                                                                                                
  Cefixime             100                                                                                                
  Ceftazidime          100                                                                                                
  Ceftriaxone          100                                                                                                
  Aztreonam            100                                                                                                
  Cephalexin           92                                                                                                 
  Ciprofloxacin        78                                                                                                 
  Tigecycline          0                                                                                                  
  Colistin             0                                                                                                  
  *E. coli* (MDR)      480                                               Ampicillin        100                            
  Amoxicillin          84.7                                                                                               
  Cephalexin           81.6                                                                                               
  Ciprofloxacin        80.6                                                                                               
  Cefixime             65                                                                                                 
  Ceftazidime          64                                                                                                 
  Aztreonam            61                                                                                                 
  Levofloxacin         51                                                                                                 
  Cotrimoxazole        33                                                                                                 
  Tigecycline          0                                                                                                  
  Colistin             0                                                                                                  

\* ESBL, extended spectrum beta lactamase.

###### 

Antimicrobial resistant in *Pseudomonas aeruginosa*, *Klebsiella* spp. *Streptococcus pneumoniae*, and *Haemophilus influenzae*.

  Microorganism                Study Area                                      No. of Isolates   Antibiotics     Resistance (%)   Reference
  ---------------------------- ----------------------------------------------- ----------------- --------------- ---------------- ------------
  *Pseudomonas aeruginosa*     Tribhuvan University Teaching Hospital (TUTH)   24                Ceftazidine     91.6             \[[@r47]\]
  Ciprofloxacin                95.8                                                                                               
  Levofloxacine                87.5                                                                                               
  Imipenem                     62.5                                                                                               
  Gentamycin                   62.5                                                                                               
  Cotrimoxazole                0                                                                                                  
  Tigecycline                  0                                                                                                  
  37                           Cefotaxime                                      100                                                
  *Klebsiella* spp.            Cefepime                                        100                                                
  Cotrimoxazole                100                                                                                                
  Ciprofloxacin                86.4                                                                                               
  Gentamycin                   83.7                                                                                               
  Levofloxacine                72.9                                                                                               
  Penicillin                   3.57                                                                                               
  Tigecycline                  0                                                                                                  
  *Streptococcus pneumoniae*   Kanti Children\'s Hospital, Kathmandu           22                Cotrimoxazole   67.86            \[[@r48]\]
  Erythromycin                 7.14                                                                                               
  Cefotaxime                   3.57                                                                                               
  *K. pneumoniae*              Mid and far western region, Nepal               36                Penicillin      88.89            \[[@r49]\]
  Ampicillin                   44.44                                                                                              
  Gentamycin                   69.44                                                                                              
  Ciprofloxacin                22.22                                                                                              
  Chloramphenicol              47.22                                                                                              
  Erythromycin                 30.56                                                                                              
  Tetracycline                 52.78                                                                                              
  Cotrimoxazole                52.78                                                                                              
  *S. pneumoniae*              30                                              Ampicillin        56.67                            
  Cotrimoxazole                63.33                                                                                              
  Penicillin                   90                                                                                                 
  Chloramphenicol              40                                                                                                 
  Gentamycin                   13.33                                                                                              
  Erythromycin                 33.33                                                                                              
  Ceftriaxone                  0                                                                                                  
  *Haemophilus influenzae*     68                                              Ampicillin        54.41                            
  Penicillin                   91.18                                                                                              
  Cotrimoxazole                47.06                                                                                              
  Chloramphenicol              32.35                                                                                              
  Gentamycin                   16.18                                                                                              
  Tetracycline                 41.18                                                                                              
  Ciprofloxacin                16.18                                                                                              

###### 

Antibiotic resistance in *Staphylococcus aureus* and Mehicillin-resistant *Staphylococcus aureus* (MRSA).

  Microorganism   Study Area or Hospital                                                No. of Isolates   Antibiotics   Resistance (%)   Reference
  --------------- --------------------------------------------------------------------- ----------------- ------------- ---------------- ------------
  *S. aureus*     Chitwan Medical College Teaching Hospital, Chitwan                    306               Penicillin    94.7             \[[@r62]\]
  Cotrimoxazole   81.7                                                                                                                   
  Cephalexin      68                                                                                                                     
  Gentamicin      60.4                                                                                                                   
  Ciprofloxacin   63.7                                                                                                                   
  Erythromycin    32.7                                                                                                                   
  Cefoxitin       43.1                                                                                                                   
  Oxacillin       39.2                                                                                                                   
  Clindamycin     27.5                                                                                                                   
  Amikacin        10.7                                                                                                                   
  Vancomycin      0                                                                                                                      
  Teicoplanin     0                                                                                                                      
  *S. aureus*     Universal College of Medical Sciences Teaching Hospital, Bhairahawa   162               Penicillin    81.5             \[[@r67]\]
  Erythromycin    71.7                                                                                                                   
  Ampicillin      87.4                                                                                                                   
  Amoxicillin     91.9                                                                                                                   
  Tetracycline    39.6                                                                                                                   
  Ciprofloxacin   26.5                                                                                                                   
  Amikacin        19                                                                                                                     
  Cloxacillin     69.1                                                                                                                   
  Vancomycin      0                                                                                                                      
  MRSA            112                                                                   Penicillin        100                            
  Cloxacillin     100                                                                                                                    
  Amoxicillin     91.8                                                                                                                   
  Ampicillin      90                                                                                                                     
  Erythromycin    68.7                                                                                                                   
  Cephalexin      66.03                                                                                                                  
  Cefazolin       57.6                                                                                                                   
  Vancomycin      0                                                                                                                      
  MRSA            Kathmandu Medical college Teaching Hospital, Kathmandu                29                Penicillin    100              \[[@r69]\]
  Oxacillin       100                                                                                                                    
  Cephalexin      75.86                                                                                                                  
  Cotrimoxazole   44.82                                                                                                                  
  Erythromycin    44.82                                                                                                                  
  Tetracycline    20.68                                                                                                                  
  Gentamicin      20.68                                                                                                                  
  Amikacin        24.13                                                                                                                  
  Ciprofloxacin   17.03                                                                                                                  
  Vancomycin      0                                                                                                                      
